EUVIMEDEUVIMED entdecken
Crossref

RNA ‐binding protein CLUH ameliorates metabolic‐associated steatohepatitis pathogenesis by maintaining ER homeostasis

Aakash Gaur, Ayushi Devendrasingh Chaudhary, Deekshita Khandelwal, Abhinav Singh, Shakti Prakash, Sarvbhaum Shukla, Sandhya Singh, Swarnali Basu, V M Prajapati, Amit Lahiri, Kumaravelu Jagavelu, Shashi Kumar Gupta iD

FEBS Letters · 29.10.2026

DOI: 10.1002/1873-3468.70494 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Letters, online erschienen am 29.10.2026. Verfasst von Aakash Gaur und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, India. Die Arbeit nennt 19 Literaturangaben. Gefördert von: CSIR-Central Drug Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CLUH, an RNA‐binding protein (RBP), is known to regulate liver metabolism under conditions of acute nutrient stress. However, its role in metabolic dysfunction‐associated steatotic liver disease (MAFLD) and metabolic dysfunction‐associated steatohepatitis (MASH) remains unknown. Here, we show that CLUH is downregulated in the methionine‐choline‐deficient (MCD) mouse model of MASH, as well as in MAFLD and MASH patients. Whereas overexpression of CLUH alleviates hepatic lipid accumulation, fibrosis, and serum AST and ALT levels induced by the MCD diet. Mechanistically, we found that CLUH regulates mitochondrial health, endoplasmic reticulum stress, and cell death by regulating Agxt2 expression. Collectively, our findings identify CLUH as a novel regulator of ER homeostasis and a potential target to treat MASH.

Schlagwörter

Stichwörter der Autor:innen

AAVAGXT2CLUHER stressMAFLDMASHRNA biologyRNA‐binding proteinfibrosissteatosis

Autor:innen und Institutionen

  • Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
  • Toxicology and Experimental Medicine Division, CSIR-Central Drug Research Institute, Lucknow, India.

ORCID-Profile: Shashi Kumar Gupta

Förderung

  • CSIR-Central Drug Research Institute

Zitieren

APA

Gaur, A., Chaudhary, A. D., Khandelwal, D., Singh, A., Prakash, S., Shukla, S., Singh, S., Basu, S., Prajapati, V. M., Lahiri, A., Jagavelu, K., & Gupta, S. K. (2026). RNA ‐binding protein CLUH ameliorates metabolic‐associated steatohepatitis pathogenesis by maintaining ER homeostasis. FEBS Letters. https://doi.org/10.1002/1873-3468.70494

Vancouver

Gaur A, Chaudhary AD, Khandelwal D, Singh A, Prakash S, Shukla S, et al. RNA ‐binding protein CLUH ameliorates metabolic‐associated steatohepatitis pathogenesis by maintaining ER homeostasis. FEBS Letters. 2026. doi:10.1002/1873-3468.70494

BibTeX
@article{Gaur2026,
  author = {Gaur, Aakash and Chaudhary, Ayushi Devendrasingh and Khandelwal, Deekshita and Singh, Abhinav and Prakash, Shakti and Shukla, Sarvbhaum and Singh, Sandhya and Basu, Swarnali and Prajapati, V M and Lahiri, Amit and Jagavelu, Kumaravelu and Gupta, Shashi Kumar},
  title = {RNA ‐binding protein CLUH ameliorates metabolic‐associated steatohepatitis pathogenesis by maintaining ER homeostasis},
  journal = {FEBS Letters},
  year = {2026},
  doi = {10.1002/1873-3468.70494}
}
Kostenlos starten →